ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Risk scoring based on DNA methylation-driven related DEGs for colorectal cancer prognosis with systematic insights

Liu, Zhe; Georgakopoulos-Soares, Ilias; Ahituv, Nadav; Wong, Ka-Chun*
Life Sciences2023-3-1DOI: 10.1016/j.lfs.2023.121413
2被引7阅读
引用收藏
分享

摘要

Colorectal cancer is a common malignant tumor of the digestive tract. Despite advances in diagnostic techniques and medications. Its prognosis remains challenging. DNA methylation-driven related circulating tumor cells have attracted enormous interest in diagnosing owing to their non-invasive nature and early recognition properties. However, the mechanism through which risk biomarkers act remains elusive. Here, we designed a risk model based on differentially expressed genes, DNA methylation, robust, and survival-related factors in the framework of Cox regression. The model has satisfactory performance and is independently verified by an external and isolated dataset in terms of C-index value, ROC, and tROC. The model was applied to Colorectal cancer patients who were subsequently divided into high- and low-risk groups. Functional annotations, genomic alterations, tumor immune environment, and drug sensitivity were analyzed. We observed that up-regulated genes are associated with epithelial cell differentiation and MAPK signaling pathways. The down-regulated genes are related to IL-7 signaling and apoptosis-induced DNA fragmentation. Interestingly, the immune system was inhibited in high-risk groups. High-frequency mutation genes tend to cooccur. High-risk score patients are related to copy number amplification events. To address the challenges, we suggested eleven and twenty-one drugs that are sensitive to low- and high-risk patients. Finally, an artificial neural network was provided to evaluate the immunotherapeutic efficiency. Taken together, the findings demonstrated that our risk score model is robust and reliable for evaluating the prognosis with novel diagnostic and treatment targets. It also yields benefits for the treatment and provides unique insights into developing therapeutic strategies.

学科与关键词

关键词
Circulating tumor cells (CTCs)DNA methylationColorectal cancer (CRC)PrognosisArtificial neural network (ANN)Risk score model
相关
加载中…
  • Predicting disease-free survival in colorectal cancer by circulating tumor DNA methylation markers
    Yang, Xin; Wen, Xiaofeng; Guo, Qin; Zhang, Yunfeng; Liang, Zhenxing; Wu, Qian; Li, Zhihao; Ruan, Weimei; Ye, Zhujia; Wang, Hong; Chen, Zhiwei; Fan, Jian-Bing; Lan, Ping*; Liu, Huashan*; Wu, Xianrui*Clinical Epigenetics, 2022, 14(1): 160.被引 3
  • Integrated Bioinformatics Analysis to Identify Abnormal Methylated Differentially Expressed Genes for Predicting Prognosis of Human Colon Cancer
    Luo, Yanbo; Sun, Fenglin; Peng, Xiaowen; Dong, Dong; Ou, Wentao; Xie, Yongke; Luo, Yuqi*International Journal of General Medicine, 2021, 14: 4745-4756.被引 8
  • Seven DNA Methylation Biomarker Prediction Models for Monitoring the Malignant Progression From Advanced Adenoma to Colorectal Cancer
    Wang, Wei; Zhang, Xuecong; Zhu, Xiaohui; Cui, Wenzhi; Ye, Danli; Tong, Guihui; Huang, Dingpeng; Zhou, Juan; Lai, Xuwen; Yan, Guangning; Li, Xia; Fan, Jianbing*; Zhu, Hongwu*; Lei, Chengyong*Frontiers in Oncology, 2022, 12: 827811.被引 1
查看全部 →

发表信息

论文状态
公开发表
期刊
Life Sciences
发表日期
2023-03-01
卷期
第 316 卷
页码
121413
DOI
10.1016/j.lfs.2023.121413
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Science Foundation of China [32170654, 32000464]; Shenzhen Research Institute, City University of Hong Kong; Strategic Interdisciplinary Research Grant of City University of Hong Kong [2021SIRG036]; Health and Medical Research Fund, the Food and Health Bureau, The Government of the Hong Kong Special Administrative Region [07181426]; City University of Hong Kong [CityU 11203520, CityU 11203221]

作者

  • L

    Liu, Zhe (第一作者)

  • G

    Georgakopoulos-Soares, Ilias

查看全部 4 位作者收起作者
  • A

    Ahituv, Nadav

  • W

    Wong, Ka-Chun (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417